SPOLANA A.S., Nejnižší kurz, Burza Praha
Poehled kurzu cenných papíru - SPOLANA | ||||||||||||||
![]() ![]() Datum | ![]() ![]() Kurz BCPP [Ke] | ![]() ![]() Zmina BCPP [%] | ![]() ![]() Objem BCPP [Ke] | ![]() ![]() Poeet BCPP [ks] | ![]() ![]() Kurz RMS [Ke] | ![]() ![]() Zmina RMS [%] | ![]() ![]() Objem RMS [Ke] | ![]() ![]() Poeet RMS [ks] |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
27.1.2003 | 43.60 | 0.00% | 0 | 0 | 58.50 | +0.51% | 0 | 0 | ||||||
24.1.2003 | 43.60 | 0.00% | 0 | 0 | 58.20 | +0.17% | 0 | 0 | ||||||
23.1.2003 | 43.60 | 0.00% | 0 | 0 | 58.10 | +0.51% | 349 | 6 | ||||||
22.1.2003 | 43.60 | 0.00% | 0 | 0 | 57.80 | -0.17% | 1 042 | 18 | ||||||
21.1.2003 | 43.60 | 0.00% | 0 | 0 | 57.90 | +1.40% | 0 | 0 | ||||||
20.1.2003 | 43.60 | 0.00% | 0 | 0 | 57.10 | +0.70% | 191 997 | 3 148 | ||||||
17.1.2003 | 43.60 | 0.00% | 0 | 0 | 56.70 | +0.71% | 0 | 0 | ||||||
16.1.2003 | 43.60 | 0.00% | 0 | 0 | 56.30 | +0.89% | 0 | 0 | ||||||
15.1.2003 | 43.60 | 0.00% | 0 | 0 | 55.80 | +0.35% | 558 | 10 | ||||||
14.1.2003 | 43.60 | 0.00% | 0 | 0 | 55.60 | +0.18% | 334 | 6 | ||||||
13.1.2003 | 43.60 | 0.00% | 0 | 0 | 55.50 | +0.36% | 0 | 0 | ||||||
10.1.2003 | 43.60 | 0.00% | 0 | 0 | 55.30 | 0.00% | 553 | 10 | ||||||
9.1.2003 | 43.60 | 0.00% | 0 | 0 | 55.30 | 0.00% | 0 | 0 | ||||||
8.1.2003 | 43.60 | 0.00% | 0 | 0 | 55.30 | +0.91% | 387 | 7 | ||||||
7.1.2003 | 43.60 | 0.00% | 0 | 0 | 54.80 | +0.36% | 0 | 0 | ||||||
6.1.2003 | 43.60 | 0.00% | 0 | 0 | 54.60 | -8.38% | 0 | 0 | ||||||
3.1.2003 | 43.60 | 0.00% | 0 | 0 | 59.60 | +9.96% | 0 | 0 | ||||||
2.1.2003 | 43.60 | 0.00% | 0 | 0 | 54.20 | -9.66% | 1 626 | 30 | ||||||
30.12.2002 | 43.60 | 0.00% | 0 | 0 | 60.00 | -0.16% | 0 | 0 | ||||||
27.12.2002 | 43.60 | 0.00% | 0 | 0 | 60.10 | 0.00% | 361 | 6 | ||||||
|
Údaje o firmách, SPOLANA
Zpravodajství k akcii SPOLANA
Okénko BIG EXPERT
Lukáš Hrma, ČSNF SICAV, a.s.
Tomáš Cverna, XTB
Léto bude pro akcie důležité, Evropa vyhlíží volby ve Francii
David Matulay, InvestingFox
Nejhodnotnější společnost v Evropě: Léky na obezitu společnosti Novo Nordisk jsou velmi žádané
Ing. Vladimír Pikora, Ph.D., Dluhopisomat
David Varga, Fintokei
Roman Vykouřil, Wonderinterest Trading s.r.o.
Vydrží koruna i nadále zpevňovat? Odpověď dostaneme brzy, záležet bude na ECB